Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

156 studies match

clinicaltrialsPublishedShowing 51–100 of 156 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06692738	A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)	recruiting	Phase 3	1,160	AstraZenecaINDUSTRY	26	Sep 18, 2026	clinicaltrials
NCT06767514	Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1(HARMONi-7)	recruiting	Phase 3	780	Summit TherapeuticsINDUSTRY	17	Sep 18, 2026